Science 37 Holdings, Inc.
SNCEDelisted Mar 12, 2024- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001819113
Science 37 Holdings, Inc. was delisted on Mar 12, 2024; its insiders filed their last Form 4 on Mar 14, 2024; 29 institutions reported holding it in 13F filings for Q4 2023, worth $13.3M in total; no superinvestor held it.
Key figures
- Market cap
- –
- Not available
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 29
- Q4 2023, −14 vs. previous quarter
- 13F value
- $13.3M
- Reported value at the end of Q4 2023
- Superinvestors holding
- 0
- At the end of Q4 2023
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2022
- $70.1M
- +17.7% year over year
- Net income, FY2022
- -$51.0M
- No comparable prior period
- Free cash flow, FY2022
- -$75.6M
- No comparable prior period
- Revenue, Q3 FY2023
- $14.9M
- −8.4% year over year
Revenue flow, FY2022
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2022: $51.0M (72.7% of revenue).
Superinvestors holding SNCE, Q4 2023
Go to the superinvestors tabNo superinvestor reported holding SNCE at the end of Q4 2023.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Science 37 Holdings, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2022 (view filing) | Nov 17 | Same day | Pellizzari Christine AChief Legal Officer | PPurchase | +5.00K | $0.81 | +$4.05K | New position5.00K after |
Top 10 13F holders, Q4 2023
See all 29 holdersThe largest institutional positions in Science 37 Holdings, Inc. at the end of Q4 2023; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Redmile Group, LLC | 990,412 | $5.29M | 0.19% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Kent Lake Capital LLC | 278,560 | $1.49M | 0.57% | +224,336+413.7% | AddedConverted for a 1-for-20 split |
| Glynn Capital Management LLC | 176,992 | $945.1K | 0.18% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Russell Investments Group, Ltd. | 169,696 | $906.2K | 0.00% | −28,531−14.4% | ReducedConverted for a 1-for-20 split |
| Vanguard Group Inc | 160,367 | $856.4K | 0.00% | −1,018−0.6% | ReducedConverted for a 1-for-20 split |
| Alphabet Inc. | 160,364 | $856.3K | 0.04% | 00.0% | UnchangedConverted for a 1-for-20 split |
| MIC Capital Management UK LLP | 117,295 | $626.4K | 0.12% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Alyeska Investment Group, L.P. | 88,319 | $471.6K | 0.00% | 00.0% | UnchangedConverted for a 1-for-20 split |
| Citadel Advisors LLC | 67,631 | $361.1K | 0.00% | −3,206−4.5% | ReducedConverted for a 1-for-20 split |
| Samsara BioCapital, LLC | 45,000 | $240.3K | 0.04% | 00.0% | UnchangedConverted for a 1-for-20 split |